EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine

Donald C Moore, Andrew S Guinigundo

Journal of the Advanced Practitioner in Oncology · 01.04.2023 · 14 (3) · 39-48

DOI: 10.6004/jadpro.2023.14.3.18 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 01.04.2023. Verfasst von Donald C Moore und 1 weiteren Autor:innen. Beteiligte Einrichtung: From Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advent of precision medicine targeting oncogenic mutations and other alterations has led to a paradigm shift in the treatment of many solid tumors and hematologic malignancies. For many of these agents, predictive biomarker testing is necessary to determine the presence of such alterations in order to select patients who are most likely to respond, and to avoid the use of ineffective and potentially harmful alternative therapy. Recent technological advances such as next-generation sequencing have facilitated the identification of targetable biomarkers in patients with cancer and thus help inform treatment decisions. Moreover, new molecular-guided therapies and associated predictive biomarkers continue to be discovered. For some cancer therapeutics, regulatory approval requires the use of a companion diagnostic to ensure proper patient selection. Advanced practitioners therefore need to be aware of current biomarker testing guidelines regarding who should be tested, how and when to test, and how these results can guide treatment decisions using molecular-based therapies. They should also recognize and address potential barriers and disparities in biomarker testing to ensure equitable care for all patients, and assist in educating patients and colleagues alike on the importance of testing and integration into clinical practice to enhance outcomes.

Autor:innen und Institutionen

  • From Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Cincinnati Cancer Advisors, Cincinnati, Ohio.

Zitieren

APA

Moore, D. C., & Guinigundo, A. S. (2023). The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine. Journal of the Advanced Practitioner in Oncology, 14(3), 39-48. https://doi.org/10.6004/jadpro.2023.14.3.18

Vancouver

Moore DC, Guinigundo AS. The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine. Journal of the Advanced Practitioner in Oncology. 2023;14(3):39-48. doi:10.6004/jadpro.2023.14.3.18

BibTeX
@article{Moore2023,
  author = {Moore, Donald C and Guinigundo, Andrew S},
  title = {The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2023},
  volume = {14},
  number = {3},
  pages = {39--48},
  doi = {10.6004/jadpro.2023.14.3.18}
}
Kostenlos starten →